The global minimally invasive glaucoma surgery (MIGS) devices market is expected to grow at a CAGR of 7.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market is driven by the increasing prevalence of glaucoma and its associated complications, which are leading to an increased demand for MIGS devices in the treatment of glaucoma.
The trabecular segment accounted for the largest share in 2017 and is expected to continue its dominance throughout the forecast period due to its ease of use and low cost. The subconjunctival segment is expected to grow at a higher CAGR than other segments due to its advantages such as reduced risk of intraocular pressure spikes, reduced risk of bleeding, and improved visual acuity post-surgery.
- The MIGS market is driven by the increasing prevalence of glaucoma, which is a leading cause of blindness in the world.
- The MIGS market is also driven by the increasing number of patients with cataracts and other eye diseases that require surgery.
- Increasing awareness about minimally invasive procedures among physicians and patients will drive the growth of this market.
- Increasing government initiatives for providing healthcare services to people with low income will also drive this market.
Industry Growth Insights published a new data on “Minimally Invasive Glaucoma Surgery (MIGS) Devices Market”. The research report is titled “Minimally Invasive Glaucoma Surgery (MIGS) Devices Market research by Types (Trabecular, Suprachoroidal, Subconjunctival), By Applications (Hospital, Ambulatory surgical centers, Ophthalmology clinics), By Players/Companies Alcon, Ellex Medical Lasers, Glaukos, Allergan, Santen, Lumenis, Ivantis, Optonol, iSTAR Medical, InnFocus, Bausch?Lomb, Neomedix, IOPtima, Abbott Medical Optics, Carl-Zeiss, New World Medical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Research Report
By Type
Trabecular, Suprachoroidal, Subconjunctival
By Application
Hospital, Ambulatory surgical centers, Ophthalmology clinics
By Companies
Alcon, Ellex Medical Lasers, Glaukos, Allergan, Santen, Lumenis, Ivantis, Optonol, iSTAR Medical, InnFocus, Bausch?Lomb, Neomedix, IOPtima, Abbott Medical Optics, Carl-Zeiss, New World Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
 Devices Industry Outlook.svg)
Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report Segments:
The global Minimally Invasive Glaucoma Surgery (MIGS) Devices market is segmented on the basis of:
Types
Trabecular, Suprachoroidal, Subconjunctival
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Ambulatory surgical centers, Ophthalmology clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Alcon
- Ellex Medical Lasers
- Glaukos
- Allergan
- Santen
- Lumenis
- Ivantis
- Optonol
- iSTAR Medical
- InnFocus
- Bausch?Lomb
- Neomedix
- IOPtima
- Abbott Medical Optics
- Carl-Zeiss
- New World Medical
 Devices Market Overview.svg)
Highlights of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Trabecular
- Suprachoroidal
- Subconjunctival
- By Application:
- Hospital
- Ambulatory surgical centers
- Ophthalmology clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Devices Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
MIGS devices are a type of cataract surgery that uses a small incision to remove the cataract. This type of surgery is less invasive than traditional cataract surgeries and may be better for people who have difficulty with other types of surgeries.
Some of the key players operating in the minimally invasive glaucoma surgery (migs) devices market are Alcon, Ellex Medical Lasers, Glaukos, Allergan, Santen, Lumenis, Ivantis, Optonol, iSTAR Medical, InnFocus, Bausch?Lomb, Neomedix, IOPtima, Abbott Medical Optics, Carl-Zeiss, New World Medical.
The minimally invasive glaucoma surgery (migs) devices market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market - Supply Chain
4.5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Forecast
4.5.1. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Absolute $ Opportunity
5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Type
5.3.1. Trabecular
5.3.2. Suprachoroidal
5.3.3. Subconjunctival
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Ambulatory surgical centers
6.3.3. Ophthalmology clinics
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Demand Share Forecast, 2019-2026
9. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Ambulatory surgical centers
9.4.3. Ophthalmology clinics
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Type
9.7.1. Trabecular
9.7.2. Suprachoroidal
9.7.3. Subconjunctival
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Demand Share Forecast, 2019-2026
10. Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Ambulatory surgical centers
10.4.3. Ophthalmology clinics
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Type
10.7.1. Trabecular
10.7.2. Suprachoroidal
10.7.3. Subconjunctival
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Demand Share Forecast, 2019-2026
11. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Ambulatory surgical centers
11.4.3. Ophthalmology clinics
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Type
11.7.1. Trabecular
11.7.2. Suprachoroidal
11.7.3. Subconjunctival
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Demand Share, 2019-2026
12. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Ambulatory surgical centers
12.4.3. Ophthalmology clinics
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Type
12.7.1. Trabecular
12.7.2. Suprachoroidal
12.7.3. Subconjunctival
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Demand Share, 2019-2026
13. Middle East & Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Ambulatory surgical centers
13.4.3. Ophthalmology clinics
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size and Volume Forecast by Type
13.7.1. Trabecular
13.7.2. Suprachoroidal
13.7.3. Subconjunctival
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market: Market Share Analysis
14.2. Minimally Invasive Glaucoma Surgery (MIGS) Devices Distributors and Customers
14.3. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Alcon
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Ellex Medical Lasers
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Glaukos
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Allergan
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Santen
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Lumenis
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ivantis
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Optonol
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. iSTAR Medical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. InnFocus
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Bausch?Lomb
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Neomedix
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. IOPtima
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Abbott Medical Optics
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Carl-Zeiss
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. New World Medical
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
